- Treatment of Metastatic Colorectal Cancer
- Society:American Society of Clinical Oncology (ASCO)
- Published:October 17, 2022
- Pharmacological Interventions for Adults With Obesity
- Society:American Gastroenterological Association (AGA)
- Published:October 20, 2022
- Drug Allergy (2022 Update)
- Society:American College of Allergy, Asthma, & Immunology (ACAAI) & American Academy of Allergy, Asthma, & Immunology (AAAI)
- Published:October 3, 2022
- Diabetes Management in Chronic Kidney Disease (CKD)
- Society: American Diabetes Association (ADA) & Kidney Disease Improving Global Outcomes (KDIGO)
- Published:October 3, 2022
- Indications for Metabolic and Bariatric Surgery
- Society:American Society for Metabolic and Bariatric Surgery (ASMBS)
- Published:October 20, 2022
- Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation
- Society:Association for Molecular Pathology (AMP) & College of American Pathologists (CAP)
- Published:October 13, 2022
- Outpatient Settings for Induction of Labour
- Society:World Health Organization (WHO)
- Published:October 5, 2022
- Mechanical Methods for Induction of Labour
- Society:World Health Organization (WHO)
- Published:October 5, 2022
- Induction of Labour At or Beyond Term
- Society:World Health Organization (WHO)
- Published:October 5, 2022
- COVID-19 Guideline Part 1: Treatment and Management
- Society:Infectious Diseases Society of America (IDSA)
- Published:October 18, 2022
- Screening, Treatment, and Management of Sleep-Related Breathing Disorders in Adults Using Oral Appliance Therapy
- Society:American Academy of Dental Sleep Medicine (AADSM)
- Published:October 10, 2022
- Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment
- Society:American College of Cardiology (ACC)
- Published:October 25, 2022
- Anxiety in Children and Adolescents: Screening — Children and adolescents aged 8 to 18 years
- Society:United States Preventive Services Taskforce (USPSTF)
- Published:October 11, 2022
- Anxiety in Children and Adolescents: Screening — Children 7 years or younger
- Society:United States Preventive Services Taskforce (USPSTF)
- Published:October 11, 2022
- Depression and Suicide Risk in Children and Adolescents: Screening
- Society:United States Preventive Services Taskforce (USPSTF)
- Published:October 11, 2022
Breast Cancer Awareness Month
October 2022
The Latest ClinicalGuidelines & FDA Approvals for Breast Cancer
- Trogarzo (Theratechnologies)
- For administration by intravenous (IV) push, treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug-resistant virus failing their current ARV regimen.
- Oxlumo (Alnylam)
- Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patients.
- Furoscix (scPharmaceuticals)
- At-Home Treatment of Congestion Due to Fluid Overload in Chronic Heart Failure.
- Boostrix (GlaxoSmithKline)
- For immunization during the third trimester of pregnancy to prevent pertussis (whooping cough) in infants younger than two months of age.
- Rinvoq (AbbVie)
- For adults with nonradiographic axial spondyloarthritis (nr-axSpA) who have objective signs of inflammation and who have had an inadequate response to or are intolerant of one or more tumor necrosis factor (TNF) inhibitors.
- Imjudo (AstraZeneca)
- Immunotherapy combination for use in the treatment of unresectable hepatocellular carcinoma (HCC).
- Tecvayli (Janssen)
- For adults with relapsed or refractory multiple myeloma after at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
Exclusive Society Guidelines & Many More!
Search, bookmark, add notes & create
your personal clinical guideline library with your digital copy or one of
our society & specialty subscription bundles
Copyright © 2022 Guideline Central, All rights reserved.